Cataract surgery has undergone remarkable refinement over the past decades, yet some of the most elegant maneuvers remain ...
As physicians across specialties encounter increasing patient interest in GLP-1 receptor agonists, it is important for them ...
Results presented at IDWeek showed prolonged antibiotic therapy beyond 12 weeks may not improve outcomes for early ...
In this video, Carolyn K. Pan, MD, a clinical professor of ophthalmology at Stanford University, discussed highlights in wet ...
Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...
An AI model significantly improved recurrence risk stratification vs. recurrence score among patients with hormone ...
A pharmacy-based intervention may help increase SGLT2 inhibitor use for patients with type 2 diabetes and chronic kidney ...
A greater proportion of women vs. men with COPD or bronchiectasis had their first health care visit within 6 months of ...
In this video, Brian T. Hill, MD, PhD, discusses data from the phase 3 EPCORE FL-1 trial, presented at the ASH Annual Meeting and Exposition.The research compared a triple drug combination therapy of ...
In this video, Matthew S. Davids, MD, spoke about the BRUIN-314 trial, one of the first head-to-head studies to compare pirtobrutinib, a noncovalent Bruton tyrosine kinase inhibitor, with ibrutinib, a ...
Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other ...
Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback